Snakebite

GEAR UP FOR DOVE SEASON WITH CHIPPEWA SNAKE BOOTS - Unparalleled Protection and Performance

Retrieved on: 
Tuesday, September 5, 2023
ASTM, Robinson, Woman, Element, Snakebite, Traction, Hunting, Nature, Vibram, Water, System, Safety, Shoemaking, Chippewa Boots, Cottonwood

FORT WORTH, Texas, Sept. 5, 2023 /PRNewswire-PRWeb/ -- With dove season just around the corner, Chippewa Boots has the perfect companion for hunters and outdoor enthusiasts: the Chippewa Snake Boots. These boots offer exceptional protection against potential snake encounters while delivering unbeatable comfort and durability in the field.

Key Points: 
  • With dove season just around the corner, Chippewa Boots has the perfect companion for hunters and outdoor enthusiasts: the Chippewa Snake Boots.
  • FORT WORTH, Texas, Sept. 5, 2023 /PRNewswire-PRWeb/ -- With dove season just around the corner, Chippewa Boots has the perfect companion for hunters and outdoor enthusiasts: the Chippewa Snake Boots.
  • Chippewa Snake Boots have been a popular choice for hunters for many years, due to their superb quality and protection against snake bites.
  • "Chippewa Snake Boots have been a staple for hunters for many years," said Taylor Morton, Public Relations Manager at Chippewa Boots.

G FUEL Partners with Sentinels Esports Organization

Retrieved on: 
Thursday, April 7, 2022
Storm, Digital Storm, Sick, ShahZaM, Organization, NEW, Apex Legends, Snakebite, Esports, PewDiePie, Lucasfilm, League of Legends: Wild Rift, The Tetris Company, CEO, Sega, Shopper, Logic, SEGA, New, Warner Bros., Tenzing Sonam, Twitter, Edible, Movement, XQc, Bethesda Game Studios, KSI, Social media, SteelSeries, History, Partnership, Coal, Video game, Capcom, Sentinel, Valorant, Twitch, Activision, Fortnite, The Walt Disney Company

NEW YORK, April 7, 2022 /PRNewswire/ -- Today G FUEL — The Official Energy Drink of Esports® — is pleased to announce a long-term partnership with Los Angeles-based esports organization Sentinels, which will include presenting sponsorship of the Sentinels' YouTube series, "unSENsored," co-branded products and more. 

Key Points: 
  • NEW YORK, April 7, 2022 /PRNewswire/ --Today G FUEL The Official Energy Drink of Esports is pleased to announce a long-term partnership with Los Angeles-based esports organization Sentinels, which will include presenting sponsorship of the Sentinels' YouTube series, "unSENsored," co-branded products and more.
  • "I've admired Sentinels' esports dominance over the past few years, and I'm excited to see what we build together," said G FUEL Founder and CEO, Cliff Morgan.
  • "G FUEL is a gaming and esports staple, so we predict great success with this partnership," said Sentinels CEO Rob Moore.
  • The Sentinels, a premier esports organization based in Los Angeles, California, have produced championship esports teams competing in Valorant, Fortnite, Apex Legends, and Halo.

GreenLight Biosciences (ENVI) partners with IAVI to accelerate COVID-19 vaccine trial in Africa

Retrieved on: 
Tuesday, November 30, 2021
Private Securities Litigation Reform Act, Forward-looking statement, Snakebite, Coalition for Epidemic Preparedness Innovations, Green-light, Tuberculosis, ENVI, African Union, Health, Partnership, Severe acute respiratory syndrome coronavirus 2, Epidemic, Clinical trial, Coalition, IAVI, Therapy, Vaccine, COVID-19, Agriculture, View, Lassa fever, Risk, Union, Africa Centres for Disease Control and Prevention, Tropical disease, RNA, Organization, RNA transfection, Antibody, Infection, Multimedia, Disease, HIV, Pharmaceutical industry

NEW YORK, Nov. 30, 2021 /PRNewswire/ -- GreenLight Biosciences has partnered with the non-profit scientific research organization IAVI to work together on a Phase I clinical trial in Africa.

Key Points: 
  • NEW YORK, Nov. 30, 2021 /PRNewswire/ -- GreenLight Biosciences has partnered with the non-profit scientific research organization IAVI to work together on a Phase I clinical trial in Africa.
  • IAVI and its partners were among the first to conduct HIV vaccine clinical trials in Africa, and since then, IAVI has sponsored more than 60 vaccine and biologics clinical trials in 13 countries.
  • GreenLight will provide its vaccine candidate for the trial and will make preparations for large-scale manufacturing of the vaccine.
  • This partnership aims to accelerate the timeline for manufacturing and deployment of GreenLight's COVID-19 vaccine candidate to Africa and potentially for export from Africa.

Immersive Online Music Education Mega-Trend To Revive Live Music

Retrieved on: 
Thursday, November 4, 2021
Educational technology, COVID-19, Hall, Specials (Sirius XM), Snakebite, Knowledge, Album, Rock and roll, Music, Modern Blues (album), Blues Alive, JAM, Human, Time (Clock of the Heart), YouTube, Stomping Ground, Joe Bonamassa, Holiday, Time, Lead, JOE, Learning, Bass, Whitesnake discography, Friends, Different Shades of Blue, Radio, Student, Snakebite: Blacktop Ballads & Fugitive Songs

Video trailers, course descriptions and pre-orders are available now at:

Key Points: 
  • Video trailers, course descriptions and pre-orders are available now at:
    Pre-orders are available now at: https://joeb.me/truefire
    "Today's music education technologies expedite the sharing of knowledge between pro players and students of music.
  • In turn, we keep music very much alive and heighten the demand for live performances," says Bonamassa.
  • This immersive learning experience allows fans to play along with Joe and the band as if they are in the same room with them.
  • You play the rhythm parts and I'll play lead, or you take the lead and I'll play rhythm.

Immersive Online Music Education Mega-Trend To Revive Live Music

Retrieved on: 
Thursday, November 4, 2021
Educational technology, COVID-19, Hall, Specials (Sirius XM), Snakebite, Knowledge, Album, Rock and roll, Music, MASTER, Modern Blues (album), Blues Alive, JAM, Human, Time (Clock of the Heart), LOS, YouTube, Stomping Ground, Joe Bonamassa, Holiday, Time, Lead, JOE, Learning, Bass, Whitesnake discography, Friends, Different Shades of Blue, Radio, Student, Snakebite: Blacktop Ballads & Fugitive Songs, Industrial design

LOS ANGELES, Nov. 4, 2021 /PRNewswire/ -- Joe Bonamassa has announced the upcoming release of his first official online guitar instructional series, an interactive and immersive experience utilizing new educational technology with JOE BONAMASSA BLUES-ROCK MASTERCLASS and IN THE JAM with JOE BONAMASSA to be released in November just in time for the holidays.

Key Points: 
  • Video trailers, course descriptions and pre-orders are available now at:
    Pre-orders are available now at: https://joeb.me/truefire
    "Today's music education technologies expedite the sharing of knowledge between pro players and students of music.
  • In turn, we keep music very much alive and heighten the demand for live performances," says Bonamassa.
  • This immersive learning experience allows fans to play along with Joe and the band as if they are in the same room with them.
  • You play the rhythm parts and I'll play lead, or you take the lead and I'll play rhythm.

BTG Specialty Pharmaceuticals Calls on Consumers and Retailers to Consider the Facts About Venom Extractors

Retrieved on: 
Tuesday, April 20, 2021
Wilderness medical emergencies, Medical specialties, Clinical medicine, Venomous snakes, Medicine, Animal attacks, Medical emergencies, Neglected tropical diseases, Snakebite, Snake venom, Antidote, Snake

These experts in the treatment of snakebites unanimously agree that venom extractors should not be used to treat snakebites.

Key Points: 
  • These experts in the treatment of snakebites unanimously agree that venom extractors should not be used to treat snakebites.
  • \xe2\x80\x9cBecause the extractors could cause an injury pattern, it goes against the physician\xe2\x80\x99s oath to do no harm.
  • The only effective and safe first aid treatment for a snakebite is a swift trip to the hospital.
  • Our current portfolio of antidotes counteracts certain snake venoms and the toxicity associated with some heart and cancer medications.

Rare Disease Therapeutics, Inc. Announces New Expanded FDA Approved Indication for Antivenom ANAVIP® for Treatment of North American Pit Viper Envenomation

Retrieved on: 
Monday, April 5, 2021
Research, Medical Supplies, FDA, Clinical trials, Biotechnology, General Health, Pharmaceutical, Health, Science, Other Science, Clinical medicine, Medicine, Antitoxins, Medical specialties, Anavip, Antivenom, Rattlesnake, Snakebite, Envenomation, Instituto Bioclon, Crotalidae polyvalent immune fab

Rare Disease Therapeutics , Inc. (RDT) today announced that the United States (US) Food & Drug Administration (FDA) approved a new expanded indication for ANAVIP (crotalidae immune F(ab)2 (equine)), an equine-derived antivenin, for the management of adult and pediatric patients with North American Pit Viper envenomation.

Key Points: 
  • Rare Disease Therapeutics , Inc. (RDT) today announced that the United States (US) Food & Drug Administration (FDA) approved a new expanded indication for ANAVIP (crotalidae immune F(ab)2 (equine)), an equine-derived antivenin, for the management of adult and pediatric patients with North American Pit Viper envenomation.
  • ANAVIP was previously indicated for the management of adult and pediatric patients with North American rattlesnake envenomation.
  • RDT exclusively markets ANAVIP in the US in partnership with manufacturer Laboratorios Silanes, S.A. de C.V., a worldwide leader in antivenom technologies.
  • ANAVIP controlled local, systemic, and hematologic symptoms for all Pit Viper envenomation patients studied1,2.

$1.58 Billion Anti-venom Market - Global Growth, Trends, COVID-19 Impact, and Forecasts 2021-2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 3, 2021
Pharmaceutical, Health, Other Health, Fictional characters, Clinical medicine, Marvel Comics characters, Antitoxins, Wilderness medical emergencies, Antivenom, Animal attacks, CSL Limited, Snakebite, Sigma-Aldrich, Merck Group, Boehringer Ingelheim

The "Anti-venom Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Anti-venom Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.
  • There is a significant increase in the number of deaths reported due to snake bites during the COVID-19 pandemic in few areas.
  • Owing to the numerous advantages key players dealing in the anti-venom market are focusing to develop polyvalent antivenoms.
  • The major market players operating in the anti-venom market include BTG PLC, Pfizer Inc., Merck KGaA (Sigma Aldrich), Boehringer Ingelheim, and CSL Limited among others.

Ophirex Receives Wellcome Trust Award to Advance Clinical Development of Novel Snakebite Treatment

Retrieved on: 
Monday, March 2, 2020
Biotechnology, Pharmaceutical, Health, Medicine, Medical specialties, RTT, Clinical medicine, Wilderness medical emergencies, Animal attacks, Medical emergencies, Venomous snakes, Snakebite, Antivenom, Antidote

The award will fund manufacturing of oral and IV varespladib, Ophirexs lead drug candidate, for use in Ophirexs upcoming, potentially pivotal clinical trial studies.

Key Points: 
  • The award will fund manufacturing of oral and IV varespladib, Ophirexs lead drug candidate, for use in Ophirexs upcoming, potentially pivotal clinical trial studies.
  • Ophirex is developing varespladib as a first-in-class, toxin-targeting antidote for snakebite, with the ultimate goal of safe and rapid administration to snakebite victims in the out-of-hospital setting where without immediate access to antivenom most snakebite deaths occur.
  • By inhibiting the progression of a key venom component called sPLA2, varespladib could mitigate many of the most common, immediately life-threatening effects of snakebite envenoming.
  • Ophirex was founded via the work of expedition doctor Matthew Lewin, MD, PhD, with support from musician and entrepreneur Jerry Harrison.

New Research Validates Clinical Value of Treating Copperhead Envenomation with CroFab®

Retrieved on: 
Tuesday, March 5, 2019
Medical specialties, Fictional characters, Agkistrodon, Antitoxins, Crotalidae polyvalent immune fab, Medicine, Venomous snakes, Wilderness medical emergencies, RTT, Snakebite, Copperhead, Agkistrodon contortrix mokasen

Additionally, it demonstrates that the effect of CroFab found in the Copperhead trial is clinically significant."

Key Points: 
  • Additionally, it demonstrates that the effect of CroFab found in the Copperhead trial is clinically significant."
  • Copperhead envenomations are often thought to be less severe than other North American Pit Viper snakebites.
  • This new data continues to support our indicated use by showing that patients bitten by copperheads recover limb function faster when treated with CroFab.
  • The researchers performed a post-hoc, secondary analysis of two BTG-sponsored trials of CroFab in patients suffering copperhead envenomation.